International Archives of Allergy and Immunology · 2011 · 29 citations · 40 references
Due to its capacity to reorient established Th2 responses toward Th1/regulatory T-cell profiles, B. bifidum represents a valid candidate adjuvant for specific immunotherapy of type I allergies.
40
Hermelijn H. Smits, Anneke Engering, Desirée van der Kleij et al. · Journal of Allergy and Clinical Immunology · 2005 · 748 citations · Full text
Ronald Dahl, Alexander Kapp, Giselda Colombo et al. · Journal of Allergy and Clinical Immunology · 2006 · 435 citations
Seasonal Allergic Rhinoconjunctivitis, Allergy, Sublingual Immunotherapy +11